|
Monday
|
Tuesday
|
Wednesday
|
Thursday
|
Friday
|
Saturday
|
Sunday
|
|---|---|---|---|---|---|---|
|
0 events,
|
0 events,
|
1 event,
Program 'Introduction to GARDskin (OECD TG 442E) for evaluation of skin sensitization hazard with dose-response option for quantitative risk assessment' Date: 30/05 Session 1: Safety: from irritation to sensitization Presenter: Andy Forreryd, SenzaGen Booth: #21 |
1 event, |
0 events,
|
0 events,
|
0 events,
|
1 event,
Come meet us at booth #22 and join our presentations to hear the latest news about GARD® and how the assays are used to fill data gaps for skin sensitizing hazard and quantitative potency assessment. Additionally, meet ToxHub, a SenzaGen Group company, and benefit from expert toxicology and regulatory advice. Presentations and Posters Our team […] |
1 event, |
1 event, |
1 event, |
0 events,
|
0 events,
|
0 events,
|
|
0 events,
|
0 events,
|
1 event,Meet us in Liverpool at the the 11th meeting of Immunotoxicology & Chemical Allergy (ITCASS) and the 30th meeting of European Research Group on Experimental Contact Dermatitis (ERGECD). |
1 event, |
1 event, |
0 events,
|
0 events,
|
|
0 events,
|
0 events,
|
0 events,
|
0 events,
|
0 events,
|
0 events,
|
0 events,
|
|
0 events,
|
0 events,
|
0 events,
|
1 event,
-
Spotlight on in vitro quantitative assessment of skin sensitizing potency. Join our upcoming webinar to explore the recent advancement in GARD® for quantitative assessment of skin sensitizing potency. This session will present a meta-analysis of GARD® data covering over 200 chemicals, including three blinded datasets generated in collaboration with industry partners. These data will demonstrate […] |
0 events,
|
0 events,
|
0 events,
|
